| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
-
|
-
|
-
|
1,500
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
|
1,500
| |
|
Operating Expenses |
|
Research Development | 20,315 | 19,764 | 20,186 | 20,924 |
|
Selling General and Administrative | 5,395 | 5,852 | 5,383 | 5,458 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(25,710)
|
(25,616)
|
(25,569)
|
(24,882)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 136 | 144 | 113 | 144 |
|
Earnings Before Interest And Taxes | (25,574) | (25,472) | (25,456) | (24,738) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (25,574) | (25,472) | (25,456) | (24,738) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (25,574) | (25,472) | (25,456) | (24,738) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(25,574)
|
(25,472)
|
(25,456)
|
(24,738)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(25,574)
|
(25,472)
|
(25,456)
|
(24,738)
|
|
0.08(1.99%) 2:53PM EDT - Nasdaq Real Time Price